Michael T. Cullen
CIK 1652996 · Executive Chairman · last filed 2023-03-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.5K
Companies
2
Total Filings
17
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBLA | Executive Chairman | 586,387 | $0.01 | $6.5K | $0 | 4 | 2023-03-29 |
| Panbela Therapeutics, Inc. (SNBP) Delisted | Exec. Chairman, Pres. & CEO | 412,571 | — | — | $0 | 2 | 2020-09-01 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-02 | — | Conv (C) | +10,495 | $0 | |
| 2019-05-23 | — | Grant (A) | — | $0 | |
| 2019-01-03 | — | Buy (P) | — | $0 | |
| 2018-03-01 | — | Grant (A) | — | $0 | |
| 2018-02-22 | — | Buy (P) | +5,000 | $0 | |
| 2016-12-14 | — | Grant (A) | — | $0 | |
| 2016-06-28 | — | Buy (P) | +50,000 | $0 |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.